Inhibition of the RAGE products increases survival in experimental models of severe sepsis and systemic infectionEmily Lutterloh, Noubar Kessimian, Steven M. Opal et al.|Critical Care|2007Cited by 166
WAY-202196, a selective estrogen receptor-beta agonist, protects against death in experimental septic shockPatricia Cristofaro, Heather A. Harris, Jhung Jhung et al.|Critical Care Medicine|2006Cited by 62
A Monoclonal Antibody Against RAGE Alters Gene Expression and is Protective in Experimental Models of Sepsis and Pneumococcal PneumoniaEirini Christaki, Debra D. Pittman, Steven M. Opal et al.|Shock|2011Cited by 50
Estrogen Receptor β Agonism Increases Survival in Experimentally Induced Sepsis and Ameliorates the Genomic Sepsis Signature: A Pharmacogenomic StudyEirini Christaki, George P. Vlasuk, Steven M. Opal et al.|The Journal of Infectious Diseases|2010Cited by 39
Recombinant Human Interleukin‐11 in Experimental<i>Pseudomonas aeruginosa</i>Sepsis in Immunocompromised AnimalsSteven M. Opal, Apurba K. Bhattacharjee, Jhung W. Jhung et al.|The Journal of Infectious Diseases|1998Cited by 36